Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

566
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
566
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

488
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
488
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

532
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

442
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

605
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
605
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

354
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
354

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of maternal obesity on ultrasonographic characterization of placenta accreta spectrum.

American journal of obstetrics & gynecology MFM·2026
Same author

Response to Letter to the Editor re: "Factors Associated With Persistent Bothersome Urinary Symptoms and Leakage After Pregnancy".

Urogynecology (Philadelphia, Pa.)·2026
Same author

Prior Stillbirth is Associated with Increased Risk of Subsequent Stillbirth.

American journal of obstetrics and gynecology·2026
Same author

Eclampsia despite magnesium sulfate prophylaxis.

American journal of obstetrics & gynecology MFM·2026
Same author

Impact of Gestational Weight Gain and Maternal Weight on Sympathetic Adaptations.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Debate: why surgery should remain central in the management of locally advanced (Stage III) non-small-cell lung cancer.

BJC reports·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
Same journal

PUBLICATIONS: July 2026.

Obstetrics and gynecology·2026
Same journal

Vaginal Natural Orifice Transluminal Endoscopic Surgery in Minimally Invasive Gynecologic Surgery: Correction.

Obstetrics and gynecology·2026
Same journal

A Contemporary View of Menopausal Hormone Therapy: Correction.

Obstetrics and gynecology·2026
Same journal

In Reply.

Obstetrics and gynecology·2026
See all related articles

Related Experiment Video

Updated: Jan 31, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K

Peripartum Cardiomyopathy.

F Gary Cunningham1, John J Byrne, David B Nelson

  • 1Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.

Obstetrics and Gynecology
|December 22, 2018
PubMed
Summary
This summary is machine-generated.

Peripartum cardiomyopathy, a heart failure during late pregnancy or postpartum, is an increasing concern. Early recognition and heart failure management are crucial for patient outcomes.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

Related Experiment Videos

Last Updated: Jan 31, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

Area of Science:

  • Cardiology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Peripartum cardiomyopathy (PPCM) is left ventricular dysfunction presenting in late pregnancy or postpartum.
  • It is a growing cause of pregnancy-associated morbidity and mortality, with incidence varying globally.
  • The exact cause is unknown but may involve genetic predisposition and hormonal factors.

Purpose of the Study:

  • To review normal cardiovascular adaptations during pregnancy.
  • To discuss the current evidence-based clinical management of peripartum cardiomyopathy.
  • To highlight the importance of early recognition and exclusion of other causes.

Main Methods:

  • This is a review article.
  • It summarizes normal cardiovascular adaptations in pregnancy.
  • It discusses current evidence-based clinical management strategies for PPCM.

Main Results:

  • PPCM incidence is estimated at 1 in 2,230 births in the US and 1 in 1,000 worldwide.
  • Management focuses on heart failure treatment, neurohormonal suppression, and preventing sequelae.
  • Outcomes and recurrence rates vary by ethnicity and geography, with mortality ranging from 3% to 40%.

Conclusions:

  • Clinical recognition and exclusion of other etiologies are vital for PPCM management.
  • While no specific therapies exist, standard heart failure treatments are employed.
  • Understanding cardiovascular changes in pregnancy aids in diagnosing and managing PPCM.